Radiomics and Radiogenomics of Non-small Cell Lung Cancer

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 12, 2018

Primary Completion Date

January 31, 2023

Study Completion Date

September 14, 2023

Conditions

Non Small Cell Lung Cancer

Interventions

DIAGNOSTIC_TEST

Radiomic signature

Assessment of radiomic signature and tumor genetic profile in patients with Non Small Cell Lung Cancer (NSCLC)

Trial Locations (1)

European Institute of Oncology, Milan

All Listed Sponsors

lead

European Institute of Oncology

OTHER

NCT06331975 - Radiomics and Radiogenomics of Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter